Patrice Carde

8.7k total citations
152 papers, 4.3k citations indexed

About

Patrice Carde is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patrice Carde has authored 152 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Pathology and Forensic Medicine, 66 papers in Oncology and 60 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patrice Carde's work include Lymphoma Diagnosis and Treatment (95 papers), Lung Cancer Treatments and Mutations (47 papers) and Viral-associated cancers and disorders (31 papers). Patrice Carde is often cited by papers focused on Lymphoma Diagnosis and Treatment (95 papers), Lung Cancer Treatments and Mutations (47 papers) and Viral-associated cancers and disorders (31 papers). Patrice Carde collaborates with scholars based in France, Netherlands and Belgium. Patrice Carde's co-authors include M. Henry‐Amar, José Thomas, M. Hayat, M Tubiana, Jean‐Marc Cosset, Evert M. Noordijk, E.M. Noordijk, M. Monconduit, Françoise Laval and A Tanguy and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

Patrice Carde

151 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrice Carde France 39 2.8k 1.6k 1.4k 877 706 152 4.3k
Dirk Hasenclever Germany 41 3.9k 1.4× 2.5k 1.6× 1.3k 0.9× 1.5k 1.7× 1.0k 1.4× 128 5.9k
Arthur T. Skarin United States 39 1.2k 0.4× 2.7k 1.7× 2.4k 1.6× 746 0.9× 568 0.8× 122 5.4k
David J. Straus United States 44 4.6k 1.7× 2.9k 1.9× 1.2k 0.8× 1.6k 1.8× 1.6k 2.2× 175 6.5k
Carol S. Portlock United States 38 4.2k 1.5× 2.7k 1.7× 966 0.7× 1.4k 1.6× 1.5k 2.1× 119 5.6k
M. Hayat France 33 1.4k 0.5× 1.4k 0.9× 916 0.6× 416 0.5× 564 0.8× 101 3.7k
Anne Kessinger United States 51 2.1k 0.8× 3.0k 1.9× 1.0k 0.7× 928 1.1× 1.4k 1.9× 213 7.4k
Chul S. Ha United States 34 1.9k 0.7× 1.8k 1.1× 693 0.5× 925 1.1× 653 0.9× 145 4.6k
Georges Fillet Belgium 37 2.1k 0.8× 1.4k 0.9× 865 0.6× 724 0.8× 1.4k 2.0× 151 5.3k
Angelo Michele Carella Italy 38 2.9k 1.0× 2.8k 1.8× 535 0.4× 1.1k 1.2× 1.6k 2.3× 234 6.3k
Cheolwon Suh South Korea 40 4.7k 1.7× 4.7k 3.0× 1.5k 1.0× 1.1k 1.3× 1.2k 1.6× 413 7.8k

Countries citing papers authored by Patrice Carde

Since Specialization
Citations

This map shows the geographic impact of Patrice Carde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrice Carde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrice Carde more than expected).

Fields of papers citing papers by Patrice Carde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrice Carde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrice Carde. The network helps show where Patrice Carde may publish in the future.

Co-authorship network of co-authors of Patrice Carde

This figure shows the co-authorship network connecting the top 25 collaborators of Patrice Carde. A scholar is included among the top collaborators of Patrice Carde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrice Carde. Patrice Carde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poullot, Elsa, François Lemonnier, Bettina Bisig, et al.. (2023). Angioimmunoblastic T‐cell lymphoma and Kaposi sarcoma: A fortuitous collision?. Histopathology. 84(3). 556–564. 1 indexed citations
2.
M’kacher, Radhia, Bruno Colicchio, Steffen Junker, et al.. (2023). High Resolution and Automatable Cytogenetic Biodosimetry Using In Situ Telomere and Centromere Hybridization for the Accurate Detection of DNA Damage: An Overview. International Journal of Molecular Sciences. 24(6). 5699–5699. 8 indexed citations
3.
Turpin, Anthony, Jean‐Marie Michot, Emmanuelle Kempf, et al.. (2017). Le lymphome de Hodgkin : stratégies thérapeutiques actuelles et futures. Bulletin du Cancer. 105(1). 81–98. 3 indexed citations
4.
Mounier, Nicolas, Pauline Brice, Serge Bologna, et al.. (2014). ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial. Annals of Oncology. 25(8). 1622–1628. 66 indexed citations
5.
Kaaij, Marleen A. E. van der, Natacha Heutte, Jannie van Echten‐Arends, et al.. (2009). Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials. Haematologica. 94(12). 1691–1697. 49 indexed citations
6.
Andréoletti, Laurent, Stéphane Flamant, Fabien Milliat, et al.. (2009). JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin’s lymphoma patients and poor clinical outcome. Annals of Oncology. 21(4). 826–832. 21 indexed citations
7.
Noordijk, Evert M., Patrice Carde, N. Dupouy, et al.. (2006). Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials. Journal of Clinical Oncology. 24(19). 3128–3135. 149 indexed citations
8.
9.
Tubiana, Maurice & Patrice Carde. (2004). Le cancer en 2004. La Presse Médicale. 33. 22–24. 1 indexed citations
10.
Jabbour, Elias, Florence Suzan, Călin Cainap, et al.. (2004). Outcome of Elderly Patients with Aggressive Non-Hodgkin's Lymphoma Refractory to or Relapsing after First-line CHOP or CHOP-like Chemotherapy: A Low Probability of Cure. Leukemia & lymphoma. 45(7). 1391–1394. 15 indexed citations
11.
Aleman, Berthe M.P., M. Henry‐Amar, Umberto Tirelli, et al.. (2001). Involved field irradiation (IFRT) does not improve outcome in patients with stage III/IV Hodgkin's lymphoma (HL) in complete remission after MOPP/ABV (M/A): Results of the randomised EORTC trial 20884. Blood. 98(11). 6 indexed citations
12.
Girinsky, T., Serge Koscielny, G. Ganem, et al.. (2001). A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment. International Journal of Radiation Oncology*Biology*Physics. 51(1). 148–155. 52 indexed citations
13.
Cosset, Jean‐Marc, M. Henry‐Amar, J.H. Meerwaldt, et al.. (1992). The EORTC trials for limited stage Hodgkin's disease. European Journal of Cancer. 28(11). 1847–1850. 47 indexed citations
14.
Carde, Patrice, M. Ricard, Michael Pfreundschuh, et al.. (1992). Immunoscintigraphy in Hodgkin's disease and anaphastic large cell lymphomas: Results in 18 patients using the iodine radiolabeled monoclonal antibody HRS-3. Annals of Oncology. 3. S53–S57. 20 indexed citations
15.
Specht, Lena, Patrice Carde, Peter Mauch, Stefano Maria Magrini, & María Teresa Santarelli. (1992). Radiotherapy versus combined modality in early stages. Annals of Oncology. 3. S77–S81. 28 indexed citations
16.
Carde, Patrice. (1992). Hodgkin's disease--I: Identification and classification.. BMJ. 305(6845). 99–102. 1 indexed citations
17.
Friedman, Samuel, M. Henry‐Amar, Jean‐Marc Cosset, et al.. (1991). Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin disease. American Journal of Hematology. 37(4). 253–257. 5 indexed citations
18.
Bosq, J., et al.. (1990). [Papulovesicular eruption of the face in chronic lymphoid leukemia].. PubMed. 117(11). 880–2. 1 indexed citations
19.
Tubiana, M, Patrice Carde, J. M. V. Burgers, et al.. (1986). Prognostic factors in non-Hodgkin's lymphoma. International Journal of Radiation Oncology*Biology*Physics. 12(4). 503–514. 19 indexed citations
20.
Rouëssé, Jacques, T. Le Chevalier, G Contesso, et al.. (1983). Chimiothérapie première dans les sarcomes des parties molles considérés comme inopérables.. 59(19). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dirk Hasenclever Breakdown of academic impact, for papers by Arthur T. Skarin Breakdown of academic impact, for papers by David J. Straus Breakdown of academic impact, for papers by Carol S. Portlock Breakdown of academic impact, for papers by M. Hayat Breakdown of academic impact, for papers by Anne Kessinger Breakdown of academic impact, for papers by Chul S. Ha Breakdown of academic impact, for papers by Georges Fillet Breakdown of academic impact, for papers by Angelo Michele Carella Breakdown of academic impact, for papers by Cheolwon Suh
Rankless by CCL
2026